Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer?

Lauren S Krill; Joel W Adelson; Leslie M Randall; Robert E Bristow

首页> 外文期刊>Gynecologic Oncology: An International Journal >Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer?

【24h】

Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer?

机译：临床评论：临床研究中的医学伦理学和衡平法的后果。对于复发性宫颈癌患者，使用不含贝伐单抗的手臂进行的确证性试验是否可行？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

These results sustain that specific HPV coinfections confer an increased risk to develop ICC/HSIL.

机译：这些结果表明，特定的HPV合并感染会增加患ICC / HSIL的风险。

著录项

来源
《Gynecologic Oncology: An International Journal》 |2014年第3期|共3页
作者
Lauren S Krill; Joel W Adelson; Leslie M Randall; Robert E Bristow;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer? [J] . Lauren S Krill, Joel W Adelson, Leslie M Randall, Gynecologic Oncology: An International Journal . 2014,第3期

机译：临床评论：临床研究中的医学伦理学和衡平法的后果。对于复发性宫颈癌患者，使用不含贝伐单抗的手臂进行的确证性试验是否可行？
2. Equipoise lost: ethics, costs, and the regulation of cancer clinical research. [J] . Stewart DJ, Whitney SN, Kurzrock R Journal of Clinical Oncology . 2010,第17期

机译：失去的平衡点：伦理，成本和对癌症临床研究的监管。
3. Destabilizing the 'equipoise' framework in clinical trials: prioritizing non-exploitation as an ethical framework in clinical research. [J] . Schlichting DE Nursing philosophy: an international journal for healthcare professionals . 2010,第4期

机译：破坏临床试验中的“平等”框架：在临床研究中将非剥削优先考虑为伦理框架。
4. DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS [C] . NOPHARGEIFMAN, ATUL J.BUTTE Pacific Symposium on Biocomputing . 2016

机译：癌症临床试验群体真正代表癌症患者吗？对癌症基因组阿特拉斯公开临床试验的比较
5. Trials and tribulations: Using patients' and physicians' preferences to enhance the efficiency and ethics of randomized clinical trials [D] . Halpern, Scott David 2002

机译：试验和磨难：利用患者和医生的偏好来提高随机临床试验的效率和伦理
6. Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices [O] . Clara Chen, Arliene Ravelo, Elaine Yu, -1

机译：来自美国社区实践的复发性胶质母细胞瘤患者含贝伐单抗和不含贝伐单抗的临床结果
7. Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials : limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials [O] . Phillips, Patrick P J, Mendel, Carl M, Burger, Divan A, 2016

机译：勘误如下：文化转换在个体患者护理决策中以及在将新方案推进到验证性临床试验中的作用有限：文化转化在个体患者护理决策中以及在将新方案推进到验证性临床试验中的作用有限

Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer?

摘要

著录项

相似文献

相关主题

期刊订阅